ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 95 filers reported holding ALLOVIR INC in Q2 2023. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,347,796 | -26.1% | 1,091,998 | +16.9% | 0.00% | – |
| Q2 2023 | $3,175,484 | -9.0% | 933,966 | +5.5% | 0.00% | – |
| Q1 2023 | $3,489,288 | -61.3% | 885,606 | -49.7% | 0.00% | – |
| Q4 2022 | $9,027,898 | +30.4% | 1,759,824 | +100.5% | 0.00% | – |
| Q3 2022 | $6,923,000 | +146.5% | 877,501 | +21.8% | 0.00% | – |
| Q2 2022 | $2,809,000 | -27.6% | 720,201 | +25.2% | 0.00% | – |
| Q1 2022 | $3,882,000 | -75.5% | 575,179 | -53.0% | 0.00% | -100.0% |
| Q4 2021 | $15,827,000 | -48.1% | 1,223,095 | +0.6% | 0.00% | -50.0% |
| Q3 2021 | $30,469,000 | -9.8% | 1,215,836 | -29.0% | 0.00% | 0.0% |
| Q2 2021 | $33,786,000 | -7.7% | 1,711,571 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $36,605,000 | +26.2% | 1,564,335 | +107.3% | 0.00% | 0.0% |
| Q4 2020 | $29,011,000 | +321.9% | 754,702 | +201.8% | 0.00% | – |
| Q3 2020 | $6,876,000 | – | 250,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $28,611 | 1.60% |
| GMT CAPITAL CORP | 2,758,846 | $14,152,880 | 0.65% |
| SVB FINANCIAL GROUP | 43,019 | $220,687 | 0.60% |
| Regency Capital Management Inc.\DE | 75,025 | $384,878 | 0.44% |
| Redmile Group, LLC | 1,907,969 | $9,787,881 | 0.40% |
| Samsara BioCapital, LLC | 82,336 | $422,384 | 0.09% |
| Alkeon Capital Management | 4,605,104 | $23,624,184 | 0.09% |
| Woodline Partners LP | 1,087,090 | $5,576,772 | 0.08% |
| XTX Topco Ltd | 53,422 | $274,055 | 0.06% |
| Virtus ETF Advisers LLC | 20,906 | $107,248 | 0.06% |